ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Nymox Pharmaceutical Corp (QB)

Nymox Pharmaceutical Corp (QB) (NYMXF)

0.092
-0.02795
( -23.30% )
Updated: 10:54:10

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 283k224k299k116k5k000
Operating Income -12.87M-13.24M-10.64M-13.33M-11.72M-12.5M-6.65M-8.79M
Pre Tax Income -13.11M-13.43M-10.59M-13.16M-11.74M-12.54M-6.58M-8.84M
Net Income -13.11M-13.43M-10.59M-13.16M-11.74M-12.54M-6.58M-8.84M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.267-0.238-0.164-0.185-0.151-0.147-0.073-0.095
EBIT -12.87M-13.24M-10.64M-13.33M-11.72M-12.5M-6.54M-8.79M
EBITDA -12.87M-13.23M-10.64M-13.33M-11.71M-12.49M-6.64M-8.78M

Your Recent History

Delayed Upgrade Clock